Celldex Therapeutics, Inc.
(NASDAQ : CLDX)

( )
CLDX After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
TMOThermo Fisher Scientific, Inc. -0.93%587.861.0%$885.12m
DHRDanaher Corp. -1.40%283.020.7%$747.15m
ABTAbbott Laboratories -1.10%124.660.8%$678.03m
MDTMedtronic Plc -1.56%106.080.6%$667.31m
ISRGIntuitive Surgical, Inc. -0.25%292.730.8%$465.19m
ALGNAlign Technology, Inc. -1.38%490.716.4%$361.78m
DXCMDexCom, Inc. -0.14%434.647.8%$341.44m
SYKStryker Corp. -0.49%257.031.3%$311.62m
BSXBoston Scientific Corp. -1.43%43.421.0%$307.23m
BDXBecton, Dickinson & Co. 0.03%263.941.0%$296.44m
AAgilent Technologies, Inc. -0.71%139.431.6%$233.49m
EWEdwards Lifesciences Corp. -0.48%115.600.4%$219.98m
IDXXIDEXX Laboratories, Inc. -1.54%511.153.8%$203.92m
ZBHZimmer Biomet Holdings, Inc. -0.33%122.861.7%$186.60m
PKIPerkinElmer, Inc. (United States) -0.97%175.092.4%$180.86m

Company Profile

Celldex Therapeutics, Inc. engages in the business of development, manufacturing and commercialization of novel therapeutics for human health care. Its drug candidates have the ability to engage the human immune system and directly inhibit tumors to treat specific types of cancer and other diseases. Its pipeline includes Varlilumab, CDX-1140, and CDX-301, and CDX-3379. The company was founded by Anthony S. Marucci and Tibor Keler in 1983 and is headquartered in Hampton, NJ.